TY - GEN 
AU - Parra-Izquierdo V
AU - Frías-Ordoñez J.S
AU - Juliao-Baños F
AU - Cuadros C
AU - Romero Sanchez C
AU - Flórez-Sarmiento C.
PY - 2024
SN - 2105705
UR - http://hdl.handle.net/10818/61978
AB - Introduction: Tofacitinib is indicated in patients with moderate to severe ulcerative colitis (UC); however, given its rapid onset of action, it may constitute an alternative in patients with hospitalized severe acute UC. There are few data on this...
LA - eng
PB - Gastroenterologia y Hepatologia
KW - Disease management
KW - Inflammatory bowel diseases
KW - Janus kinase inhibitors
KW - Therapeutics
KW - Tofacitinib
KW - Ulcerative colitis
TI - Colombian experience with the use of tofacitinib in severe acute ulcerative colitis: A case series study [Experiencia colombiana con el uso de tofacitinib en colitis ulcerosa aguda grave: estudio de serie de casos]
DO - 10.1016/j.gastrohep.2023.10.003
ER -